Winton Capital »

Larimar Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $160k 52k 3.05

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Larimar Therapeutics

Deerfield Management Company
Blue Owl Capital Holdings
BlackRock
Defilade Capital Management
Driehaus Capital Management
Vanguard Capital Management
Rtw Investments
AQR Capital Management
Marshall Wace
DAFNA Capital Management
Goldman Sachs Group
Citadel Advisors
Geode Capital Management
Qube Research & Technologies
Vanguard Portfolio Management

View all funds holding Larimar Therapeutics